• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

VICL:US

1.2500 USD 0.0300 2.34%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Vical Inc (VICL)

Open: 1.2600 Day's Range: 1.2300 - 1.2800 Volume: 537,157
Previous Close: 1.2800 52wk Range: 1.0100 - 4.5100 1-Yr Rtn: -63.87%

Stock Chart for VICL

No chart data available.
  • VICL:US 1.2500
  • 1D
  • 1M
  • 1Y
1.2800
Interactive VICL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VICL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2719
Est. EPS (USD) (12/2014) -0.1650
Est. PEG Ratio -
Market Cap (M USD) 108.55
Shares Outstanding (M) 86.84
30 Day Average Volume 1,247,552
Price/Book (mrq) 1.8472
Price/Sale (ttm) 12.6598
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VICL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VICL

Vical Incorporated develops gene-based pharmaceutical products for human therapy. The Company develops cancer product candidates, as well as develops vaccines for infectious diseases and gene-based delivery of therapeutic proteins for other disorders.

Vijay B SamantPresident/CEO/Acting CFOIgor P BilinskySenior VP:Corporate Dev
Anthony A RamosVP:Finance/Chief Acctg OfficerMammen P Mammen JrVP:Clinical Vaccines
More Company Profile & Key Executives for VICL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil